Hepatic MCPIP1 protein levels are reduced in NAFLD patients and are predominantly expressed in cholangiocytes and liver endothelium
Background and Aims:. NAFLD is characterized by the excessive accumulation of fat in hepatocytes. NAFLD can range from simple steatosis to the aggressive form called NASH, which is characterized by both fatty liver and liver inflammation. Without proper treatment, NAFLD may further progress to life-...
Main Authors: | Natalia Pydyn, Justyna Kadluczka, Piotr Major, Tomasz Hutsch, Kinga Belamri, Piotr Malczak, Dorota Radkowiak, Andrzej Budzynski, Katarzyna Miekus, Jolanta Jura, Jerzy Kotlinowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2023-03-01
|
Series: | Hepatology Communications |
Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000008 |
Similar Items
-
MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver FibrosisSummary
by: Natalia Pydyn, et al.
Published: (2024-01-01) -
Activity of MCPIP1 RNase in tumor associated processes
by: Katarzyna Miekus, et al.
Published: (2019-10-01) -
Substrate specificity of human MCPIP1 endoribonuclease
by: Mateusz Wilamowski, et al.
Published: (2018-05-01) -
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
by: Paulina Marona, et al.
Published: (2022-09-01) -
The endonuclease activity of MCPIP1 controls the neoplastic transformation of epithelial cells via the c-Met/CD44 axis
by: Paulina Marona, et al.
Published: (2025-01-01)